Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

Similar articles for PubMed (Select 23300162)

1.

Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age.

Gans HA, Yasukawa LL, Sung P, Sullivan B, DeHovitz R, Audet S, Beeler J, Arvin AM.

J Infect Dis. 2013 Feb 15;207(4):574-82. doi: 10.1093/infdis/jis719. Epub 2013 Jan 8.

2.

Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.

Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM.

J Infect Dis. 2004 Jul 1;190(1):83-90. Epub 2004 May 26.

3.
4.

Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.

Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.

Vaccine. 2006 Jan 30;24(5):683-90. Epub 2005 Aug 24.

PMID:
16154241
5.

Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.

Wong-Chew RM, Beeler JA, Audet S, Santos JI.

J Med Virol. 2003 Jun;70(2):276-80.

PMID:
12696117
6.

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.

Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y.

JAMA. 1998 Aug 12;280(6):527-32.

PMID:
9707142
7.

Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.

Benn CS, Aaby P, Balé C, Olsen J, Michaelsen KF, George E, Whittle H.

Lancet. 1997 Jul 12;350(9071):101-5.

PMID:
9228962
8.

Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years.

Njie-Jobe J, Nyamweya S, Miles DJ, van der Sande M, Zaman S, Touray E, Hossin S, Adetifa J, Palmero M, Burl S, Jeffries D, Rowland-Jones S, Flanagan K, Jaye A, Whittle H.

Vaccine. 2012 Mar 28;30(15):2543-50. doi: 10.1016/j.vaccine.2012.01.083. Epub 2012 Feb 5.

9.

Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.

Johnson CE, Nalin DR, Chui LW, Whitwell J, Marusyk RG, Kumar ML.

Pediatrics. 1994 Jun;93(6 Pt 1):939-44.

PMID:
8190581
10.

Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines.

Whittle H, Aaby P, Samb B, Cissé B, Kanteh F, Soumaré M, Jensen H, Bennett J, Simondon F.

Pediatr Infect Dis J. 1999 Jan;18(1):53-7.

PMID:
9951981
11.

Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.

Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.

J Infect Dis. 2004 Jan 15;189(2):254-7. Epub 2004 Jan 5.

12.

Persistence of measles neutralizing antibody related to vaccine and natural infection acquired before HIV infection.

Isa MB, Pavan JV, Sicilia Don P, Grutadauria S, Martinez LC, Giordano MO, Masachessi G, Barril PA, Nates SV.

Epidemiol Infect. 2014 Aug;142(8):1708-12. doi: 10.1017/S0950268813002628. Epub 2013 Oct 21.

PMID:
24139476
13.

Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.

Martins C, Garly ML, Bale C, Rodrigues A, Benn CS, Whittle H, Aaby P.

Vaccine. 2013 Nov 19;31(48):5766-71. doi: 10.1016/j.vaccine.2013.08.044. Epub 2013 Aug 28.

14.

Seroconversion after measles vaccination at nine and fifteen months of age.

Işik N, Uzel N, Gökçay G, Kiliç A, Yilmaz G, Sadikoğlu B, Diri S.

Pediatr Infect Dis J. 2003 Aug;22(8):691-5.

PMID:
12913768
15.

Independence of measles-specific humoral and cellular immune responses to vaccination.

Jacobson RM, Ovsyannikova IG, Vierkant RA, Pankratz VS, Poland GA.

Hum Immunol. 2012 May;73(5):474-9. doi: 10.1016/j.humimm.2012.02.016. Epub 2012 Mar 3.

16.

Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.

Borràs E, Urbiztondo L, Costa J, Batalla J, Torner N, Plasencia A, Salleras L, Domínguez À; Working Group for the Study of Measles Immunity in Children.

Epidemiol Infect. 2012 Sep;140(9):1599-606. Epub 2011 Nov 11.

PMID:
22074684
17.

A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine.

Haralambieva IH, Ovsyannikova IG, O'Byrne M, Pankratz VS, Jacobson RM, Poland GA.

Vaccine. 2011 Jun 15;29(27):4485-91. doi: 10.1016/j.vaccine.2011.04.037. Epub 2011 May 1.

18.

Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.

Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.

Pediatr Infect Dis J. 1996 Aug;15(8):687-92.

PMID:
8858673
19.

Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.

Whittle HC, Campbell H, Rahman S, Armstrong JR.

Lancet. 1990 Oct 27;336(8722):1046-8.

PMID:
1977029
20.

Increasing the time of exposure to aerosol measles vaccine elicits an immune response equivalent to that seen in 9-month-old Mexican children given the same dose subcutaneously.

Wong-Chew RM, García-León ML, Espinosa-Torres Torrija B, Hernández-Pérez B, Cardiel-Marmolejo LE, Beeler JA, Audet S, Santos-Preciado JI.

J Infect Dis. 2011 Aug 1;204(3):426-32. doi: 10.1093/infdis/jir278.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk